These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 28441215)
21. Real-life practice of methotrexate toxicity monitoring in juvenile idiopathic arthritis in Germany, Switzerland and Austria: results of a cross-sectional assessment conducted in 2012. Akmatov MK; Stumme M; Pessler F Clin Exp Rheumatol; 2016; 34(3):548-53. PubMed ID: 27156925 [TBL] [Abstract][Full Text] [Related]
22. Adverse consequences of low-dose methotrexate medication errors: data from French poison control and pharmacovigilance centers. Vial T; Patat AM; Boels D; Castellan D; Villa A; Theophile H; Torrents R; Kassai B Joint Bone Spine; 2019 May; 86(3):351-355. PubMed ID: 30243781 [TBL] [Abstract][Full Text] [Related]
23. Trying to improve care: the Morbidity and Mortality Conference in a division of rheumatology. Batthish M; Tse SM; Feldman BM; Baker GR; Laxer RM J Rheumatol; 2014 Dec; 41(12):2452-8. PubMed ID: 25362651 [TBL] [Abstract][Full Text] [Related]
24. The use of methotrexate in childhood rheumatic diseases. Wallace CA Arthritis Rheum; 1998 Mar; 41(3):381-91. PubMed ID: 9506564 [No Abstract] [Full Text] [Related]
25. Methotrexate and bone marrow suppression: standard collaborative care will be made more difficult. Clarke AK BMJ; 2003 May; 326(7399):1145; author reply 1145-6. PubMed ID: 12764000 [No Abstract] [Full Text] [Related]
35. High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients-A Preliminary Study. Sandhu A; Dhir V; Bhatnagar A; Dhawan V; Kaur J; Sood A; Naidu S; Ahmad S; Varma N; Sharma A; Sharma S Ther Drug Monit; 2017 Apr; 39(2):157-163. PubMed ID: 28107255 [TBL] [Abstract][Full Text] [Related]
36. The Safety of Intravenous Cyclophosphamide in the Treatment of Rheumatic Diseases. Woytala PJ; Morgiel E; Ćuczak A; Czesak-Woytala K; Wiland P Adv Clin Exp Med; 2016; 25(3):479-84. PubMed ID: 27629736 [TBL] [Abstract][Full Text] [Related]
37. Relationship between 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism and methotrexate related toxicity in patients with autoimmune diseases receiving folic acid supplementation. Speletas M; Papadopoulos N; Daiou C; Katodritou E; Pavlitou-Tsiontsi A; Galanopoulou V Ann Rheum Dis; 2005 Dec; 64(12):1791-2. PubMed ID: 16284346 [No Abstract] [Full Text] [Related]
38. The remarkable spectrum of methotrexate toxicities. McKendry RJ Rheum Dis Clin North Am; 1997 Nov; 23(4):939-54. PubMed ID: 9361162 [TBL] [Abstract][Full Text] [Related]
39. Medical treatment of adolescents with rheumatic disease. Hollister JR Adolesc Med; 1998 Feb; 9(1):163-70, vii. PubMed ID: 10961259 [TBL] [Abstract][Full Text] [Related]
40. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. Ostensen M; Hartmann H; Salvesen K J Rheumatol; 2000 Aug; 27(8):1872-5. PubMed ID: 10955326 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]